Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 05:30PM GMT
Release Date Price: $13.59 (+1.34%)
Brandon Couillard
Jefferies Financial Group - Senior Analyst

All right. So we'll go ahead and get started. Thanks. Good afternoon. Welcome to Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostic sector here at Jefferies.

Very happy to have Fluidigm with us at the conference this year. And here to share the overview of the company, CFO, Vikram Jog; and as well as Agnes Lee, who heads up the IR in the audience.

I'll turn it over to you, Vikram.

Vikram Jog
Fluidigm Corporation - CFO

Thanks, Brandon, and thank you, Jefferies, for inviting us to this conference one more year. I'm really glad to have the opportunity to talk to you about Fluidigm and the significant progress that we have made over the last one year.

During this presentation, I will be making forward-looking statements, and discussing GAAP and non-GAAP financial information; all of which can be found and reconciled to one another on the investors section of our website.

Fluidigm is a leading tools and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot